These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Nateglinide may increase high-molecular weight adiponectin in type 2 diabetic patients with hypoadiponectinemia. Iwase M; Iino K; Doi Y; Asano T; Iida M Diabetes Res Clin Pract; 2008 Dec; 82(3):e19-22. PubMed ID: 18849086 [TBL] [Abstract][Full Text] [Related]
10. Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial. Dashora UK; Sibal L; Ashwell SG; Home PD Diabet Med; 2007 Apr; 24(4):344-9. PubMed ID: 17298589 [TBL] [Abstract][Full Text] [Related]
11. Postprandial lipid profile in patients with type 2 diabetes. Katsiki N; Kolovou G Curr Med Res Opin; 2014 Jan; 30(1):121. PubMed ID: 24024786 [No Abstract] [Full Text] [Related]
12. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes. Carroll MF; Gutierrez A; Castro M; Tsewang D; Schade DS J Clin Endocrinol Metab; 2003 Nov; 88(11):5248-54. PubMed ID: 14602757 [TBL] [Abstract][Full Text] [Related]
13. [Prandial glucose regulator and insulin secretagogue; glinide and its combination therapy]. Nakashima E Nihon Rinsho; 2015 Mar; 73(3):416-23. PubMed ID: 25812367 [TBL] [Abstract][Full Text] [Related]
14. Treating type 2 diabetes. When diet and exercise aren't enough, a broad range of medications can help control our blood sugar. Blackburn GL Health News; 2004 Aug; 10(8):4-5. PubMed ID: 15551454 [No Abstract] [Full Text] [Related]
15. Type 2 diabetes management. Nelson G Br J Community Nurs; 2002 Jan; 7(1):5. PubMed ID: 11823724 [No Abstract] [Full Text] [Related]
16. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes]. Liebl A Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835 [TBL] [Abstract][Full Text] [Related]
17. Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia. Ambavane V; Patil R; Ainapure SS J Postgrad Med; 2002; 48(3):246-8. PubMed ID: 12432213 [No Abstract] [Full Text] [Related]
18. Efficacy, tolerability and safety of nateglinide in combination with metformin. Results from a study under general practice conditions. Schatz H; Schoppel K; Lehwalder D; Schandry R Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):262-6. PubMed ID: 12951631 [TBL] [Abstract][Full Text] [Related]
19. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure. Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145 [TBL] [Abstract][Full Text] [Related]
20. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes. Vakkilainen J; Mero N; Schweizer A; Foley JE; Taskinen MR Diabetes Metab Res Rev; 2002; 18(6):484-90. PubMed ID: 12469362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]